Funding for this research was provided by:
the Outstanding Scientific Fund of Shengjing Hospital (201705)
the Research project of China Medical University (S526)
Received: 28 March 2022
Accepted: 8 July 2022
First Online: 25 July 2022
: The studies involving human participants were reviewed and approved by the Ethics Committee of Shengjing Hospital of China Medical University (Shenyang, China). The patients/participants provided their written informed consent to participate in this study. The animal study was reviewed and approved by Ethics Committee of China Medical University (Shenyang, China).
: Not applicable.
: The authors declare that they have no competing interests.